The present invention relates to the targeted delivery of a delivery vehicle construct which specifically binds to and stimulates endocytosis into cells expressing the urokinase plasminogen activator receptor (uPAR), and particularly human airway epithelia. The delivery vehicle construct comprises a portion of uPA and a cargo linked thereto and is useful for the targeted delivery of the cargo to a cell. In one aspect of the invention, the uPA portion of the delivery vehicle construct comprises the wild-type uPA, a fragment of uPA which has the PAI-1 binding region deleted, or a uPA peptide comprising amino acids 13–19 and is useful for the targeted delivery of the cargo to cells, and in particular to airway epithelia. The present invention also provides a method for delivering the delivery vehicle construct to a cell. The method comprises the steps of (a) contacting a target cell with a delivery vehicle construct comprising a uPA portion and a cargo portion; and (b) obtaining a desired result in the target cell.
Patent
Targeting vector to the urokinase plasminogen activator receptor
United States Patent and Trademark Office
11/07/2006
PDM V1.0, Open Access
Abstract
Details
- Title: Subtitle
- Targeting vector to the urokinase plasminogen activator receptor
- Creators
- Michael J Welsh (Inventor)Paola T Drapkin (Inventor)
- Contributors
- University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
- Resource Type
- Patent
- Publisher
- United States Patent and Trademark Office; United States
- Patent
- US Patent 7,132,405; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 10/442,880; 05/21/2003
- Number of pages
- 20 pages
- Language
- English
- Date published
- 11/07/2006
- Academic Unit
- UI Research Foundation; Neurology; Molecular Physiology and Biophysics; Neurosurgery; Internal Medicine
- Record Identifier
- 9983761951102771
Metrics
20 File views/ downloads
13 Record Views